insulin Flashcards

1
Q

structure of insulin

A

C-term A chain linked via disulphide bonds to N-term B chain

C-peptide cleaved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

implication of C-peptide levels

A

arise only from endogenous insulin, indicates endo synthesis of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what stimulates insulin release

A

glucose, amino acids, parasympathetic release of ACh

increase intracellular Ca2+ in b-cells –> insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what suppresses insulin release

A

adrenaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

properties of GLUT2

A

high Km, low affinity
expressed in liver and pancreatic b-cells

constitutively expressed in b-cells

liver – uptake of excess glucose
b-cell – regulation of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

properties of GLUT 1,3

A

basal glucose uptake

all mammalian tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

properties of GLUT4

A

main uptake of glucose

primarily in muscle and fat cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

actions of insulin

A
  • facilitate glucose uptake
  • decrease rate of lipid and protein breakdown
  • increase glycolysis
  • decrease glycogen breakdown
  • increase glycogen synthesis
  • promote cell division and growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

termination of insulin action

A

internalisation and metab by lysosomes of insulin-receptor complex

receptors recycled to membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

insulin clearance

A

first-pass in liver: removes ~50% of endo insulin

kidney: 50% insulin clearance from systemic circulation (main clearance for exo insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

indications for insulin therapy

A

type I: must take insulin (deficiency)

type II: severe hyperglycaemia, glycemic target cannot be reached w 2/more oral hypoglycaemic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

types of insulin needed

A

basal: suppress hepatic glucose pdtn overnight and b/w meals

prandial: to dispose of glucose after eating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

types of insulin therapy

A

all administered via subcutaneous injection, diff rates of absorption

  • rapid acting
  • short acting
  • intermediate acting
  • long acting (cannot be mixed)
  • premixed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

rapid acting insulin

A

insulin lispro, aspart, glulisine

modification of aa –> changes to charge/conformation of insulin at physiological pH
(weaken propensity to self-associate through charge repulsion – rapid absorption of monomers)

injected j before meals, dose can be adjusted prop to amt of food

shorter duration of action –> lower incidence of hypoglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

short acting insulin

A

structurally similar to endo human insulin

self aggregates in subcutaneous tissue –> delayed onset by 30-60mins (inject 30 min before meal)

IV – immediate

greater risk of hypoglycaemia than rapid acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

intermediate acting

A

neutral protamine hagedorn (NPH) insulin – recombinant human insulin + protamine

cloudy appearance (vs other types: clear)
relatively cheaper

precipitate crystals that slowly release – longer duration of action

delayed onset: 3-4h

greater risk of hypoglycaemia: high variability in NPH action, long peak effect – must eat as insulin level peaks

taken twice a day (effect: ~12h)

17
Q

long acting insulin

A

insulin glargine, detemir

virtually no plasma peak, act as basal insulin

cannot be mixed w other insulin

glargine: formulated at pH4, aggregates and slowly release at pH 7.4

detemir: c14 fatty acid side chain – increase self-association, reversible binding to albumin –> prolong action

more predictable fasting blood glucose, lower variation than NPH –> reduce risk of hypog

18
Q

what insulin cannot be mixed

A

glargine/detemir + other insulin
glulisine + non-NPH insulin

19
Q

routes of administration for insulin

A

subcutaneous – default
IV – emergency, immediate
nasal – rapid, highly vascularised lungs

avoid IM
avoid: bruises, scar tissue, near joints, groin, navel (belly button)

20
Q

adverse effects of insulin

A

hypoglycaemia

lipohypertrophy – lipogenic nature of insulin, rotate site of injection to reduce incidence

lipodystrophy (more relevant when animal insulin used)

21
Q

factors affecting PK of insulin

A
  • site of injection – blood flow
  • depth of injection – superficial: slower, deeper: faster
  • larger vol delay absorption
  • exercise muscle – increase rate of absorption
  • massage site/heat: increase rate of absorption
22
Q

effect of steroid on blood glucose

A

steriod: drug induced hyperg

monitor blood glucose closely, may need to increase insulin